Process development approaches for engineered B cell medicines, a new class of cellular medicines

Authors

• Alan Gilbert, Be Biopharma, USAFollow
• Mark Lalli, Be Biopharma, Cambridge, MA, USA
• Rashmi Kshirsagar, Be Biopharma, Cambridge, MA, USA
• Andre Stanlie, Be Biopharma, Cambridge, MA, USA

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Alan Gilbert, Mark Lalli, Rashmi Kshirsagar, and Andre Stanlie, "Process development approaches for engineered B cell medicines, a new class of cellular medicines" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/127